|
[1] Rittner K,Schreiber V,Erbs P,et al. Targeting of adenovirus vectors carrying a tumor cell-specific peptide: in vitro and in vivo studies. Cancer Gene Ther,2007,14(5):509-518.
[2] Belousova N,Krendelchtchikova V,Curiel D T,et al. Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein. J Virol,2002,76(17):8621-8631.
[3] Mizuguchi H,Koizumi N,Hosono T,et al. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob. Gene Therapy,2001,8(9):730-735.
[4] Pasqualini R,Koivunen E,Kain R,et al. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res,2000,60(3):722-727.
[5] Riemann D,Kehlen A,Langner J. CD13——not just a marker in leukemia typing. Immunol Today,1999,20(2):83-88.
[6] Corti A,Curnis F,Arap W,et al. The neovasculature homing motif NGR: more than meets the eye. Blood,2008,112(7):2628-2635.
[7] Xia H,Anderson B,Mao Q,et al. Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium. J Virol,2000,74(23):11359-11366.
[8] Liu S,Mao Q,Zhang W,et al. Genetically modified adenoviral vector with the protein transduction domain of Tat improves gene transfer to CAR-deficient cells. Biosci Rep,2009,29(2):103-109.
[9] Santoro A,Rimassa L,Sobrero A F,et al. Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy. Eur J Cancer,2010,46(15):2746-2752.
[10] Spitaleri A,Mari S,Curnis F,et al. Structural basis for the interaction of isoDGR with the RGD-binding site of αvβ3 integrin. J Biol Chem,2008,283(28):19757-19768.
[11] Jullienne B,Vigant F,Muth E,et al. Efficient delivery of angiostatin K1-5 into tumors following insertion of an NGR peptide into adenovirus capsid. Gene Ther,2009,16(12):1405-1415.
|
